Lipoprotein(a) [Lp(a)], an apolipoprotein B100-containing lipoprotein, is a well-established risk factor for atherosclerotic cardiovascular disease[[9], [10], [11], [12], [13]] and aortic stenosis [14,15] Lp(a) is produced by the liver, and has pro-inflammatory, atherogenic, and thrombotic effects [[9], [10], [11], [12], [13], [14], [15], [16]] Lp(a) levels are approximately 70 % to ≥90 % genetically determined, and median levels vary by ethnicity [[9], [10], [11], [12], [13]]. Here, LPA is linked to aortic stenosis.